INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,927,000 | +46.8% | 533,636 | +37.8% | 0.18% | +54.2% |
| Q1 2019 | $4,718,000 | -11.1% | 387,391 | -16.8% | 0.12% | -20.0% |
| Q4 2018 | $5,306,000 | -50.5% | 465,844 | -5.6% | 0.15% | -29.9% |
| Q3 2018 | $10,711,000 | +15.3% | 493,608 | -6.1% | 0.21% | +11.5% |
| Q2 2018 | $9,286,000 | -20.7% | 525,502 | -5.5% | 0.19% | -19.3% |
| Q1 2018 | $11,707,000 | +150.3% | 556,156 | +72.2% | 0.24% | +167.4% |
| Q4 2017 | $4,678,000 | +88.5% | 323,049 | +105.4% | 0.09% | +111.9% |
| Q3 2017 | $2,482,000 | -59.9% | 157,305 | -58.7% | 0.04% | -51.7% |
| Q1 2017 | $6,190,000 | -21.0% | 380,911 | -26.6% | 0.09% | -14.7% |
| Q4 2016 | $7,833,000 | +31.6% | 519,108 | +32.9% | 0.10% | +59.4% |
| Q3 2016 | $5,954,000 | -72.2% | 390,650 | -29.2% | 0.06% | -70.2% |
| Q2 2016 | $21,433,000 | +95.4% | 552,104 | +39.9% | 0.22% | +119.4% |
| Q1 2016 | $10,970,000 | -43.9% | 394,606 | +8.6% | 0.10% | -37.6% |
| Q4 2015 | $19,551,000 | +99.4% | 363,471 | +48.5% | 0.16% | +96.2% |
| Q3 2015 | $9,803,000 | – | 244,842 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |